Home » Stocks » BVXV

BiondVax Pharmaceuticals Ltd. (BVXV)

Stock Price: $3.13 USD -0.13 (-3.99%)
Updated December 1, 4:00 PM EST - Market closed
After-hours: $3.09 -0.04 (-1.28%) Dec 1, 7:41 PM

Stock Price Chart

Key Info

Market Cap 36.06M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 11.52M
EPS (ttm) -2.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day December 1
Last Price $3.13
Previous Close $3.26
Change ($) -0.13
Change (%) -3.99%
Day's Open 3.26
Day's Range 3.05 - 3.34
Day's Volume 548,518
52-Week Range 2.50 - 51.10

More Stats

Market Cap 36.06M
Enterprise Value 62.12M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 11.52M
Float n/a
EPS (basic) n/a
EPS (diluted) -2.30
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 325,312
Short Ratio 0.14
Short % of Float n/a
Beta 2.64
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 11.71
Revenue n/a
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash -26.06M
Net Cash / Share -2.26
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -67.84%
ROE n/a
ROIC n/a
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $3.13
Target: 30.00
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions ILS.

Financial Overview

Operating Income-78.35-77.07-23.66-11.90-11.30-8.14-7.64-9.13
Net Income-109-87.73-34.55-9.18-10.20-7.76-8.04-9.33
Shares Outstanding32726120113510654.2947.9541.53
Earnings Per Share-0.33-0.34-0.17-0.07-0.10-0.14-0.17-0.22
Operating Cash Flow-77.06-57.19-10.05-9.65-10.27-7.57-4.21-7.01
Capital Expenditures-7.43-23.59-4.51-0.02-0.03-0.03-0.20-0.31
Free Cash Flow-84.49-80.79-14.56-9.67-10.30-7.60-4.40-7.31
Cash & Equivalents72.4775.8871.3825.3235.4911.6319.88-
Total Debt13194.36------
Net Cash / Debt-58.82-18.4871.3825.3235.4911.6319.88-
Book Value-65.05-31.2256.2525.6233.5516.5923.99-
Numbers in millions ILS, except per-share numbers.

Company Profile

Company Details

Full Name BiondVax Pharmaceuticals Ltd.
Country Israel
Employees 25
CEO Ronald Babecoff

Stock Information

Ticker Symbol BVXV
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: BVXV


BiondVax Pharmaceuticals, a clinical stage biopharmaceutical company, focuses on developing and commercializing immunomodulation therapies for infectious diseases primarily in Israel. Its product candidate is M-001, a synthetic peptide-based protein, which is in Phase III clinical trials for treatment of seasonal and pandemic strains of the influenza virus. The company was founded in 2003 and is headquartered in Jerusalem, Israel.